| Revision as of 20:46, 24 July 2002 editRobert Merkel (talk | contribs)Extended confirmed users8,354 editsNo edit summary← Previous edit | Revision as of 17:44, 26 April 2004 edit undoTexture (talk | contribs)19,623 editsm User:Next edit → | ||
| Line 1: | Line 1: | ||
| Research into the disease may, I'm afraid, be limited due to the fact that the disease impacts people primarily after their prime income generating/tax paying days are over. -- ] | Research into the disease may, I'm afraid, be limited due to the fact that the disease impacts people primarily after their prime income generating/tax paying days are over. -- ] | ||
| ----- | ----- | ||
Revision as of 17:44, 26 April 2004
Research into the disease may, I'm afraid, be limited due to the fact that the disease impacts people primarily after their prime income generating/tax paying days are over. -- Coasting
On the other hand, they're the most politically active age group -- they've more leisure time. There's a reason politicians in the US and elsewhere don't dare touch pensions, for example.
The article incorrectly stated that Alzheimer first identified the symptoms of the disease and therefore (citing the authoritative reference from the historian of the institute where they worked) I took the liberty of making this correction: The symptoms of the disease as a distinct nosologic entity were first identified by Emil Kraepelin, and the characteristic neuropathology was first observed by Alois Alzheimer in 1906. In this sense, the disease was co-discovered by Kraepelin and Alzheimer, who worked in Kraepelin's laboratory. Because of the overwhelming importance Kraepelin attached to finding the neuropathological basis of psychiatric disorders, Kraepelin made the generous decision that the disease would bear the name of Alzheimer (J. Psychiat. Res, 1997, Vol 31, No. 6, pp. 635-643).
What's a "nosologic entity"? Is there a simpler alternative term that would do the job? --Robert Merkel